The majority of cases of cervical cancer are primarily caused by HPV. Researchers from the University College London in the UK and the Innsbruck University in Austria have created a more precise prediction test that can identify cell alterations that can result in cervical cancer. Given that it can detect the DNA markers of various […]
First targeted therapy for HER2-Low breast cancer receives FDA approval
The Food and Drug Administration (FDA) has approved targeted therapy for a newly defined subset of breast cancer. The drug trastuzumab-deruxtecan, also known by the brand name Enhertu, will now be available for people included in the HER2-low breast cancer subtype. HER2 is a protein known as “human epidermal growth factor receptor 2.” It promotes the growth […]
Annual screening before age 50 leads to lower proportions of advanced breast cancer
A new study led by University of Ottawa professors has found Canadian provinces that annually screen women aged 40-49 had lower proportions of advanced breast cancer compared to women aged 50-59 from provinces that did not hold annual mammograms. The study, published in the latest edition of Current Oncology, found lower proportions of stage 2, 3 […]
